Serum Levels of Asprosin, a Novel Adipokine, Are Significantly Lowered in Patients with Acromegaly
Background. Asprosin is a novel identified adipokine secreted mainly by white adipose tissue, which is elevated in metabolic diseases such as diabetes and obesity. Acromegaly is a syndrome caused by pituitary growth hormone (GH) cell adenoma with excessive GH secretion. Serum adipocytokines levels m...
Saved in:
| Main Authors: | Xiaoan Ke, Lian Duan, Fengying Gong, Yuelun Zhang, Kan Deng, Yong Yao, Linjie Wang, Hui Pan, Huijuan Zhu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | International Journal of Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2020/8855996 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Association Between the Serum Level of Asprosin and Metabolic Parameters in Adult Growth Hormone Deficiency: A Cross-Sectional Study
by: Hongbo Yang, et al.
Published: (2024-01-01) -
Somatic GNAS mutations in acromegaly: prevalence, clinical features and gender differences
by: Yamei Yang, et al.
Published: (2024-12-01) -
Hyperprolactinemia caused by extra-pituitary prolactin secretion: a systematic review
by: Yixin Lu, et al.
Published: (2025-07-01) -
SERUM ADIPOKINES AND ADIPOKINE RECEPTORS IN COLON CANCER PATIENTS WITH METABOLOC SYNDROM
by: N. V. Yunusova, et al.
Published: (2016-02-01) -
High-coverage targeted lipidomics revealed a novel serum lipid dysregulation profile in adult growth hormone deficiency
by: Hongbo Yang, et al.
Published: (2024-12-01)